Research Report Synthetic Biology Market Expected to Grow at a CAG

Title: Synthetic Biology Market Expected to Grow at a CAGR of 45% by 2022
Summary:
Global Synthetic Biology Market Professional Survey Report 2018 presents an in-depth assessment
of the Synthetic Biology including enabling technologies, key trends, market drivers, challenges,
standardization, regulatory landscape, deployment models, operator case studies, opportunities,
future roadmap, value chain, ecosystem player profiles and strategies. The report also presents
forecasts for Synthetic Biology investments from 2018 till 2022.
The global synthetic biology market is forecast to reach $38.8 billion by 2022, at a CAGR of 45%
during the forecast period (2014 - 2022).
Global Synthetic Biology Sales (K Units) and Revenue (Million USD) Market by Top
Manufacturers (2017-2022)
Amyris New England Biolabs
DuPont Novozymes
GenScript USA Royal DSM
Intrexon Synthetic Genomics
Integrated DNA Technologies Thermo Fisher Scientific
Global Synthetic Biology Sales (K Units) and
Revenue (Million USD) Market Split by
Product Type
Global Synthetic Biology Sales (K Units) by
Application (2017-2022)
Xeno-nucleic Acids Environmental Application
Oligonucleotides Medical Application
Chassis Organisms Industrial Application
Enzymes
Cloning and Assembly Kits
Geographically, this report is segmented into several key Regions, with Sales, Sales, revenue, Market
Share (%) and Growth Rate (%) of Synthetic Biology in these regions, from 2013 to 2022 (forecast),
covering North America, Europe, China, Japan, Southeast Asia, India.
Inquire for Sample Copy of This Report at: